Table 8.
Site (ICD-O-3 Code) | Total | Male | Female | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5-Year total | Annual Average | % of All Tumors | Rate | 95% CI | 5-Year total | Annual Average | % Malignant | % Non-Malignant | Rate | 95% CI | 5-Year total | Annual Average | % Malignant | % Non-Malignant | Rate | 95% CI | |
Frontal, temporal, parietal, and occipital lobes of the brain (C71.1-C71.4) | 74,890 | 14,978 | 15.3% | 4.23 | 4.20-4.26 | 41,746 | 8,349 | 91.7% | 8.3% | 4.99 | 4.94-5.04 | 33,144 | 6,629 | 88.5% | 11.5% | 3.57 | 3.53-3.61 |
Frontal lobe (C71.1) | 32,856 | 6,571 | 7.9% | 1.88 | 1.86-1.90 | 17,467 | 3,493 | 92.3% | 7.7% | 2.11 | 2.07-2.14 | 15,389 | 3,078 | 89.9% | 10.1% | 1.68 | 1.65-1.71 |
Temporal lobe (C71.2) | 24,233 | 4,847 | 5.8% | 1.36 | 1.34-1.38 | 14,447 | 2,889 | 90.8% | 9.2% | 1.72 | 1.69-1.74 | 9,786 | 1,957 | 86.8% | 13.2% | 1.05 | 1.03-1.07 |
Parietal lobe (C71.3) | 13,987 | 2,797 | 3.4% | 0.78 | 0.76-0.79 | 7,706 | 1,541 | 93.4% | 6.6% | 0.91 | 0.89-0.93 | 6,281 | 1,256 | 89.1% | 10.9% | 0.66 | 0.64-0.68 |
Occipital lobe (C71.4) | 3,814 | 763 | 0.9% | 0.21 | 0.21-0.22 | 2,126 | 425 | 86.4% | 13.6% | 0.26 | 0.24-0.27 | 1,688 | 338 | 83.8% | 16.2% | 0.18 | 0.17-0.19 |
Cerebrum (C71.0) | 7,213 | 1,443 | 1.7% | 0.42 | 0.41-0.43 | 3,872 | 774 | 83.2% | 16.8% | 0.47 | 0.46-0.49 | 3,341 | 668 | 79.5% | 20.5% | 0.38 | 0.37-0.39 |
Ventricle (C71.5) | 4,097 | 819 | 1.0% | 0.26 | 0.25-0.26 | 2,218 | 444 | 42.1% | 57.9% | 0.28 | 0.27-0.29 | 1,879 | 376 | 40.1% | 59.9% | 0.23 | 0.22-0.24 |
Cerebellum (C71.6) | 8,892 | 1,778 | 2.1% | 0.56 | 0.55-0.57 | 4,737 | 947 | 63.9% | 36.1% | 0.61 | 0.59-0.63 | 4,155 | 831 | 55.6% | 44.4% | 0.52 | 0.50-0.53 |
Brain stem (C71.7) | 6,174 | 1,235 | 1.5% | 0.40 | 0.39-0.41 | 3,346 | 669 | 76.1% | 23.9% | 0.43 | 0.42-0.45 | 2,828 | 566 | 77.4% | 22.6% | 0.37 | 0.35-0.38 |
Other brain (C71.8-C71.9) | 33,498 | 6,700 | 8.1% | 1.90 | 1.88-1.92 | 17,687 | 3,537 | 83.8% | 16.2% | 2.16 | 2.12-2.19 | 15,811 | 3,162 | 78.9% | 21.1% | 1.68 | 1.65-1.70 |
Spinal cord and cauda equina (C72.0-C72.1) | 12,905 | 2,581 | 3.1% | 0.77 | 0.76-0.79 | 6,782 | 1,356 | 27.6% | 72.4% | 0.84 | 0.82-0.86 | 6,123 | 1,225 | 26.4% | 73.6% | 0.71 | 0.70-0.73 |
Cranial nerves (C72.2-C72.5) | 28,850 | 5,770 | 6.9% | 1.65 | 1.63-1.67 | 13,501 | 2,700 | 5.7% | 94.3% | 1.60 | 1.57-1.63 | 15,349 | 3,070 | 5.5% | 94.5% | 1.70 | 1.67-1.72 |
Other nervous system (C72.8-C72.9) | 2,548 | 510 | 0.6% | 0.15 | 0.14-0.15 | 1,295 | 259 | 56.8% | 43.2% | 0.16 | 0.15-0.17 | 1,253 | 251 | 55.8% | 44.2% | 0.14 | 0.13-0.15 |
Meninges (cerebral and spinal) (C70.0-C70.9) | 159,403 | 31,881 | 38.4% | 8.84 | 8.79-8.88 | 43,365 | 8,673 | 2.2% | 97.8% | 5.30 | 5.25-5.35 | 116,038 | 23,208 | 1% | 99% | 11.97 | 11.90-12.04 |
Pituitary (C75.1-C75.2) | 74,426 | 14,885 | 17.9% | 4.46 | 4.42-4.49 | 33,614 | 6,723 | 0.7% | 99.3% | 4.07 | 4.03-4.12 | 40,812 | 8,162 | 0.5% | 99.5% | 4.93 | 4.88-4.98 |
Pineal (C75.3) | 1,775 | 355 | 0.4% | 0.11 | 0.11-0.12 | 1,040 | 208 | 75% | 25% | 0.13 | 0.13-0.14 | 735 | 147 | 44.8% | 55.2% | 0.09 | 0.09-0.10 |
Olfactory tumors of the nasal cavity (C30.0 d) | 740 | 148 | 0.2% | 0.04 | 0.04-0.05 | 438 | 88 | 100% | 0% | 0.05 | 0.05-0.06 | 302 | 60 | 100% | 0% | 0.03 | 0.03-0.04 |
TOTAL | 415,411 | 83,082 | 100.0% | 23.79 | 23.71-23.86 | 173,641 | 34,728 | 39.5% | 60.5% | 21.09 | 20.99-21.20 | 241,770 | 48,354 | 22.7% | 77.3% | 26.31 | 26.21-26.42 |
a. Annual average cases are calculated by dividing the five-year total by five.
b. Rates are per 100,000 and are age-adjusted to the 2000 US standard population.
c. The sites referred to in this table are loosely based on the categories and site codes defined in the SEER site/histology validation list.
d. ICD-O-3 histology codes 9522-9523 only.
- Counts and rates are not presented when fewer than 20 cases were reported for the specific category. The suppressed cases are included in the counts and rates for totals.
CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results Program; CI, confidence interval